Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Under certain circumstances edits to an order can result in unintended scheduled interventions on the intellivue clinical information portfolio. if the clinical team does not recognize that extra scheduled interventions exist a patient may receive interventions or additional medication doses that are not intended.